Qui sommes-nous ? About us
L'ANSM en bref
About us
Nos engagements
Nos missions
Notre périmètre
Notre organisation
Déontologie et transparence
Publications institutionnelles
Publications scientifiques
Rejoignez-nous !
Notre agenda
 
Actualités
Nos articles
Nos campagnes
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions liées aux médicaments
Décisions liées aux produits sanguins et autres produits biologiques
Décisions liées aux médicaments dérivés du plasma
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Injonctions
Décisions de police sanitaire
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur

Our organisation

A+ A-
> Consultez la version française

Two bodies are tasked with ANSM’s governance: a Management Board, and a Scientific Board.

In addition, since 2019, the Agency’s policy of openness to civil society has resulted in healthcare system users being systematically involved in our consultative bodies of expertise. We are convinced of the need to work alongside patients and healthcare professionals to ensure that our action addresses the challenges that they face on a daily basis.

For this reason, our decisions are based on the opinions of several consultative committees, in which the expertise of representatives of civil society, their perspective, and their vision of the health sector allow objective and informed decision-making.
 

Scientific Board

The Scientific Board monitors the consistency of the ANSM's scientific strategy by taking into account evolving knowledge concerning the efficacy and safety of health products.

It formulates opinions and recommendations for the director general, in the context of referrals or self-referrals, relating to open and cross-cutting themes and public health issues. It contributes to the ANSM’s forward-looking thinking on future issues and challenges.

Its 16 members are appointed by the Ministry of Health. They sit for a renewable three-year term:
  • ten members are appointed on the basis of their scientific expertise following a call for applicants issued by the Agency;
  • six renowned scientists including scientists from outside France are appointed on the advice of the Minister for Research.

Names of members of the Scientific Board 2023-2026

Ten members appointed on the basis of their expertise in healthcare products

  • ANKRI Joël
  • BRUNEAUX François
  • CASTEL Patrick
  • CHASKIEL Patrick
  • CLERE Nicolas
  • EISINGER François
  • OLIVEIRA-MARTINS Sofia
  • POUGHEON Dominique         
  • SAUTOU Valérie         
  • THIERRY Jean-Pierre

Six renowned scientists including scientists from outside Franceists from outside France

  • BELLISSANT Éric
  • EZAN Éric
  • HAMDANI Jamila
  • JAULENT Marie-Christine
  • ODENT Sylvie
  • PACCAUD Fred